Kastalia is Filter‘s deputy editor. She previously worked at half a dozen mainstream digital media outlets and does not recommend the drug war coverage at any of them. For a while she was a syringe program peer worker in NYC, where she did outreach hep C testing and navigated participants through treatment. She also writes with Jon Kirkpatrick.
Acting Attorney General Todd Blanche has signed an order moving state-licensed medical marijuana products from Schedule I to Schedule III…
On April 15, the Centers for Disease Control and Prevention published its most recent monthly provisional drug overdose death count,…
Illinois lawmakers are considering a proposal to pilot long-acting injectable medication for opioid use disorder (MOUD) within the state prison…
In the year since Department of Health and Human Services Secretary Robert F. Kennedy Jr. announced his plan to consolidate…
Nine months after Rhode Island passed a law regulating the sale of kratom, the partial opioid agonist that has divided…
President Donald Trump has released his proposed budget for Fiscal Year 2027, which outlines sweeping cuts to essentially everything that…
On April 6 the White House announced a Health Alert Network (HAN) advisory warning about the effects of medetomidine, an…
Three years in the making, the legislative push to place xylazine under Schedule III of the federal Controlled Substances Act…
In Illinois, a bill to authorize an overdose prevention center (OPC) pilot is working its way through the House. HB…
Two years after its approval by the Food and Drug Administration, opioid-overdose reversal product Rezenopy is about to make its…